Medication info

Dagliem Tablet 2/500 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Hwa Il Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201907770 · Approved 2019.11.06

This product's status changed to Expired on 2024.11.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient’s current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient’s current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased according to blood glucose monitoring results, with experience of administration up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional benefit at doses above 4mg daily, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Hwa Il Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Non-insulin dependent diabetes
View approved original text

This medication is used for patients with non-insulin dependent diabetes, i.e., Type 2 Diabetes. It is administered when blood sugar control is insufficient with diet and exercise alongside monotherapy with glimepiride or metformin. It can also replace combination therapy of glimepiride and metformin. This helps manage blood sugar levels effectively, contributing to the improvement of diabetes.

How to take

Adult dose

This medicine is administered 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient’s current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient’s current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased according to blood glucose monitoring results, with experience of administration up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional benefit at doses above 4mg daily, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so treatment should be temporarily discontinued and a doctor consulted if there is a rapid decline in kidney function or symptoms of dehydration (severe diarrhea, vomiting, fever, decreased fluid intake, etc.). This medication should not be administered to patients with kidney function below a certain level, and situations where kidney function may change should be monitored carefully. In patients with cardiovascular disease or at high risk for cardiovascular death, caution should be exercised regarding the use of this medication, and the risks and benefits of treatment should be thoroughly discussed. This medication should not be used in certain patient groups, including those with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, pregnant or lactating women, and severe renal impairment. As there is a high risk of hypoglycemia in the early stages of treatment, blood sugar levels should be carefully monitored, especially in the elderly or patients with irregular meals, malnutrition, vigorous exercise, or alcohol intake. Gastrointestinal disturbances (nausea, vomiting, etc.) may occur during treatment but are mostly transient, and if symptoms are severe, medical advice should be sought. If allergic reactions or blood-related symptoms (thrombocytopenia, anemia, etc.) occur, medical staff should be informed immediately, and in severe cases, treatment should be discontinued. This medication may interact with various drugs that affect blood sugar control, so if other medications are being used, it is essential to inform medical staff. Pregnant or breastfeeding women are advised not to use this medication and should switch to insulin therapy if necessary. Caution should be exercised when administering to children and the elderly, especially the elderly who may require dosage adjustments and regular kidney function testing due to renal impairment. In cases of overdose, hypoglycemia or lactic acidosis may occur, so immediate emergency treatment should be obtained, and glucose should be consumed in cases of hypoglycemic symptoms. Regular monitoring of blood sugar, kidney function, and blood tests should be conducted to assess treatment effectiveness and side effects during treatment. Caution is necessary when driving or operating machinery due to potential hypoglycemia or impaired agility. Keep out of reach of children, and do not transfer to another container for safety.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal bloating
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
Show 38 more
  • metallic taste
  • visual impairment
  • erythema
  • itching
  • urticaria
  • rash
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • granulocytopenia
  • agranulocytosis
  • pancytopenia
  • macrocytic anemia
  • elevated liver enzymes
  • liver dysfunction
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • abdominal pain
  • abdominal bloating
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • cardiac arrest
  • rectal carcinoma
  • vertigo
  • abnormal liver function
  • arthralgia
  • facial swelling
  • erectile dysfunction
  • hair loss
  • flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, preferably at a temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy for a longer duration.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.